title: The role of PET and PET/CT in managing the care of lymphoma patients.
abstract: The clinical use of PET and PET/CT aids physicians and patients in developing lymphoma prognoses, specifically for Hodgkin disease and aggressive types of non-Hodgkin lymphoma. PET and PET/CT are used to initially stage lymphoma, restage disease, and check for remission or recurrence of malignant tissue after treatment. PET/CT is more sensitive and specific than CT alone and has better accuracy concerning lymphoma relapse and remission. In conjunction with other tests, such as blood laboratory work and biopsy, PET and PET/CT allow the lymphoma to be staged appropriately and treated correctly. Results from PET and PET/CT contribute to the formation of a specialized treatment plan that leads to the best possible care for each individual patient. PET and PET/CT positively affect the management of patients with lymphoma.
authors.affiliation: Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA. westley.evans@childrens.harvard.edu
authors.forename: Westley C
authors.initials: WC
authors.lastname: Evans
authors.forename: David
authors.initials: D
authors.lastname: Gilmore
authors.forename: Jeffrey
authors.initials: J
authors.lastname: English
mesh_terms: D000328:Adult; D002951:Citrates; D005260:Female; D019788:Fluorodeoxyglucose F18; D005708:Gallium; D006801:Humans; D008223:Lymphoma / Q000000981:diagnostic imaging* / Q000473:pathology; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging / Q000473:pathology; D009367:Neoplasm Staging; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals; D012074:Remission Induction; D012189:Retrospective Studies; D012680:Sensitivity and Specificity; D014057:Tomography, X-Ray Computed / Q000379:methods*
chemical_list: D002951:Citrates; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D005708:Gallium; C103850:gallium citrate